The group’s CEO, Lars Fruergaard Jørgensen, received a total remuneration package of DKK 57.1 million ($7.97 million) in 2024, of which 42% is not yet finally determined, and 45% is deferred.

But rather than the fist-pumping tech bros or mixed martial arts fighters that made up Trump’s circle at his inauguration, Frederiksen went instead to a rather more reserved character: a softly spoken ...

Kære Business-læser. Her kommer din daglige nyhedsoverflyvning fra Berlingskes erhvervsredaktion. I denne update får du en herlig blanding af europæisk økonomi og lidt USA – det er jo svært at undgå i ...

Novo Nordisk’s new CEO Lars Fruergaard Joergensen says it is considering M&A to shore up performance as its key US diabetes sales come under pressure. In an interview with Reuters, Joergensen ...

Forud for en høring i det amerikanske Senat tager administrerende direktør i Novo Nordisk Lars Fruergaard Jørgensen endnu engang til genmæle over for beskyldningerne om, at det danske medicinalselskab ...

Novo Nordisk chief executive Lars Fruergaard Jørgensen was taken to task by US lawmakers over the price of the company's semaglutide drugs for diabetes and obesity at a congressional hearing ...

Måske kunne Novo-topchef Lars Fruergaard Jørgensen selv være gået en runde. Havde han gjort det i tide, var han måske sluppet for at komme i Ekstra Bladet. Man kan også undre sig over ...

Men sådan bliver det ikke ved. Hvis et forslag fra EU-Kommissionen bliver til virkelighed, kan life science-sektoren i Europa ende som »et museum«, lyder advarslen fra Lars Fruergaard Jørgensen, ...